Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Isolated Monostotic Fibrous Dysplasia of the Temporal Bone: A Case Report and Review of Literature

Mamthashri V

Department of Oral and Maxillofacial Surgery, Government Dental College and Research Institute, Bangalore, India

Abstract: Fibrous dysplasia is a category of fibro-osseous lesions which demonstrates replacement of normal bone by a fibrous connective tissue matrix, within which varying amounts of metaplastic osteoid, immature and mature bone & in some instances, cementum like tissue are deposited. Among the two types of fibrous dysplasia, like the monostotic forms and the polyostotic form; the monostotic type of fibrous dysplasia is more commonly seen. We present a case of an isolated monostotic fibrous dysplasia of the temporal bone with clinical, radiographic, microscopic features along with the management of the same.

Keywords: fibrous dysplasia, temporal bone, monostotic, polyostotic, surgical management

Citation: Mamthashri V, Isolated Monostotic Fibrous Dysplasia of the Temporal Bone: A Case Report and Review of Literature. International Journal of Dental Sciences and Research, 5 (6). 146-149. January 2017. doi:10.12691/ijdsr-5-6-3

1. Introduction

Fibrous dysplasia (FD) is a developmental disorder of bone which may be due to reactive or unknown etiologies and they all behave in a benign fashion with a defective osteoblastic differentiation and maturation [1]. It was first described by McCune and Bruch and the term “Fibrous Dysplasia” was coined by Lichtenstein [2]. The three variants of FD seen are unifocal/monostotic type of FD, where a single bone is involved, a multifocal/polyostotic type where multiple bones are involved and McCune Albright Syndrome (MAS) when the polyostotic type bone lesions are associated with cutaneous pigmentation i.e. Cafe-au-lait spots (Jaffe-Lichenstein syndrome) and disorders of endocrine system like pituitary adenomas, precocious puberty or hyperthyroidism [3]. Fibrous dysplasia involving the craniofacial bones is of particular importance in oral and maxillofacial surgery as they cause severe deformities and dysfunctions. These lesions are more commonly predominant in males compared to females (2: 1) and preference for Caucasians [4]. Even though the craniofacial skeleton is a frequent site of the disease, temporal bone affection is rare [5]. We report a case of an isolated monostotic fibrous dysplasia of the temporal bone with a review the literature.

2. Case Report

A 38 years old woman presented herself to our department with a chief complaint of swelling and pain of the right temporal region. The swelling had started as a small growth and increased gradually over a period of 4 years. On clinical examination, a diffuse, lobulated bony hard mass was palpable extending from the preauricular region till the middle of the zygomatic arch on the right side (Figure 1 and Figure 2). Pain was localized, chronic and intermittent in nature. There were no associated symptoms like ear pain, hearing loss and facial nerve weakness or paralysis.

Figure 1. Preoperative frontal view showing swelling view in the right preauricular region

Figure 2. Preoperative lateralview of the right preauricular region.

A computed tomography scan of the face was taken and the lateral 3D computed tomography scan revealed a radiopaque, multilobed bony mass extending from the temporal region to the zygomatic arch sparing the glenoid fossa (Figure 3).

No ear canal stenosis was noted. No other bones were found to be involved except the bone at the temporal region.

Figure 3. A lateral 3D CT depicting the size shape and location of the fibrous dysplasia of the temporal bone

Blood and other laboratory investigations were found to be normal. A biopsy was done under local anesthesia. The histological slide showed fibrous tissue stroma with irregularly shaped bone trabeculae confirming the diagnosis of monostotic fibrous dysplasia (Figure 4).

Figure 4. Histological slide showing fibrous tissue stroma and irregular bony trabeculae

Figure 5. A preauricular approach to expose the lesion

After an informed consent was obtained from the patient, shewas operated for surgical resection and recontouring of the lesion through a preauricular approach under general anesthesia (Figure 5). The lesion was segmentally resected (Figure 6) conservatively and bone was contoured according to the anatomical shapes and defining the bony facial contour. After achieving a good hemostasis, the flap was closed in layers (Figure 7) and a postoperative follow-up of the patient was done for a week (Figure 8). A periodic follow up of the patient was done at regular intervals for any recurrence of the lesion.

Figure 6. Resected specimen

Figure 7. Closure of the incision after resection and surgical recontouring of the lesion

Figure 8. Postoperative photograph

3. Discussion

Fibrous dysplasia involving the temporal bones has been well documented in the literature [5,6,7,8,9,10,11]. The involvement of temporal bone is more common with craniofacial polyostotic FD (PFD) or MAS [12], and less common in monostotic disease [13,14]. Monostotic type contributes to approximately 80-85% of fibrous dysplasia with a less degree of bone deformity as compared to that of the polyostotic type. This form occurs most frequently in the age range of 10-70 years of age with the mean age being 27 years. The male to female ratio of about 2: 1 is usually seen with a tendency to develop at early childhood [1,4]. The ratio of left and right sides affected is approximately equal to each other and seen commonly in the ribs, femur, tibia and craniofacial bones in the descending order of frequency. Monostotic FD are although truly termed for mandibular lesions, the maxillary lesions often involving the adjacent bones (Zygoma, sphenoid, occiput) are not strictly monostotic. Hence it is ideally termed as craniofacial fibrous dysplasia which is more appropriate for these lesions. The incidence of MFD constitutes for about 70%, PFD for about 30% and McCune Albright Syndrome is for about 3% [15]. Following maxilla and mandible, all the craniofacial bones may be involved but involvement of temporal and occipital bones are unusual. It also occurs in an isolated form. In the isolated variety, no extracranial lesions are present. Site of involvement most commonly include the frontal, sphenoid, maxillary and ethmoidal bones with the occipital and temporal bones being least commonly affected. The craniofacial skeleton is one of its predictive sites and therefore the temporal bone may become involved. The involvement of temporal bone between all cranial bones is around 18%. It is also observed that the temporal bone is affected unilaterally, but bilaterally involvement may be seen in PFD cases [15,16]. The characteristic signs are the expansion of bone, thinned cortical layer and displacement of surrounding structures [16,17]. These findings were consistent with our present case. Diagnoses of these lesions are possible with biopsy and our case of temporal FD was also confirmed with a biopsy done under local anesthesia prior to surgical intervention.

Radiological appearances can be distinguished as 3 types: pagetoid or ground glass appearance (56%), sclerotic (23%) and cystic (21%) lesions [15,17,18]. The radiological features in our case demonstrated an increase in size and bone density associated with areas of sclerosis and radiolucency and the CT scan showed a transition zone between normal and dysplastic bone. A differential diagnosis of a eosinophilic granuloma is made in a solitary lesion may and Hand-Schuller-Christian disease in multiple lesions [15,17].

In some cases, there are associated symptoms like severe cosmetic deformities, recurrent fractures of the involved bone, hearing loss and facial nerve weakness or paralysis. Hearing loss is seen as a result of narrowing of the external auditory canal due to the surrounding FD and fixation of the ossicles within the epitympanum from adjacent involved bone, ranges from mild to moderate degree. An obstruction of the canal with cerumen and desquamated skin leads to a potential complication like cholesteatoma [14,19]. A comprehensive audiology examination and ear evaluation is recommended once the temporal bone is found to be involved with FD [14,20,21,22]. If the lesion causes sudden facial weakness due to expansion, then a surgical decompression is considered. Therefore, surgical intervention is required to relieve the obstruction, chronic infection and other complications [23,24]. In the present case, a surgical correction of excision of the lesion and recontouring was done for cosmetic purpose and also as per the patient’s desire. There was no hearing loss or facial nerve weakness noted. Postoperatively the patient had uneventful healing and showed no signs of recurrence during the follow up period of more than 5 years.

While pain is common among FD patients [25], more data relating pain to the location and activity of disease and the effectiveness of various treatment modalities like the use of NSAIDs with and without narcotic treatment; bisphosphonates [26] such as alendronate, pamidronate, or zoledronic acid for craniofacial FD has been considered for pain reduction and to reduce the rate of growth of the lesion [27,28,29]. The efficacy of these osteoclast inhibitor therapies such as bisphosphonates or denosumab in slowing the growth of craniofacial FD and reducing intractable craniofacial FD pain is yet to be determined by further studies. Also, newlyemerging therapies like RANK ligand inhibition (i.e. denosumab) in the treatment of FD-related pain or reduction in growth remains to be determined [30].

Surgery remains the mainstay of therapy especially in the absence of curative medicine in FD. FD should be readily classified by a thorough and good clinical history and examination followed by radiologic studies, open biopsy and then a decision is made for a surgical intervention. More often a conservative treatment is beneficial, particularly if important or vital structures (such as cranial nerves or the carotid artery) are placed at risk, rather than a radical and aggressive resection of the lesion due to its benign nature. A periodic and long follow up period warrants and keeps the recurrence under check. Radiation therapy is ineffective and contraindicated because of the possibility of malignant transformation [5,7].

The recommended treatment for FD includes:

1. Early and aggressive screening for efficient management of endocrinopathies (particularly growth hormone excess).

2. A detailed history, clinical examination and radiographic analysis are very essential especially in lesions where a confirmatory biopsy is not possible.

3. Surgical treatment is delayed till until the skeletal maturity in lesions which are quiescent.

4. However, if there are symptoms or rapid changes in the lesion then a surgical contouring or resection may be carried out prior to skeletal maturity, though a high risk of recurrence is seen.

5. Immediate surgical intervention and evaluation is done for active disease (rapid growth, new onset of pain or paresthesia, visual or hearing changes).

6. The use of bisphosphonates may be considered as an adjuvant for refractory pain at the site of the lesion.

7. Amulti-disciplinary approach is vital for the successful management of patients with FD, particularly PFD and MAS [31].

4. Conclusion

In summary, fibrous dysplasia involving the temporal bone can be treated relatively conservatively due to its benign nature, with the primary goal being preservation of existing function and surgery being reserved for patients with functional impairment or a cosmetic deformity. With the current understanding of the biologic and clinical characteristics of FD and recommendations for the clinical management in the craniofacial region along with the advent of modern imaging modalities and histopathologic analysis, diagnosis is made very simple and straightforward. Therefore, treatment is customized for each patient based on their needs, the size and sites of involvement and the associated symptoms that follow it.

Acknowledgements

The authors have received permission from the patients depicted in the manuscript to use their photographs for this purpose.

Funding

None.

Competing Interests

The authors declare that they have no competing interests.

References

[1]   | Papadakis CE, Skoulakis CE, Prokopakis EP, Nikolidakis AA, Bizakis JG, Velegrakis GA, Helidonis ES. Fibrous dysplasia of the temporal bone: report of a case and a review of its characteristics. Ear Nose Throat J 2000; 79(1): 52-7.
[2]   | Lichtenstein L. Polyostotic fibrous dysplasia Arch Surg 1938; 36: 874-98.
[3]   | Tochina R, Sunami K, Yamane H. Fibrous dysplasia of the temporal bone with cholesteatoma. ActaOtolaryngol 2004; 554: 47-49.
[4]   | Donnelly MJ, McShane DP, Burns H. Monostotic fibrous dysplasia of the temporal bone with associated lynphadenopathy. Ear Nose Throat J 1994; 73(5): 328-30.
[5]   | Nager GT, Holliday MJ. Fibrous dysplasia of the temporal bone: update with case reports. Ann Otol Rhinol Laryngol.1984; 93: 630-3.
[6]   | Nager G, Kennedy D, Kopstein E. Fibrous dysplasia: A review of the literature and its manifestations in the temporal bone. Ann Otol Rhinol Laryngol 1982; 92: 1-52.
[7]   | Lambert PR, Brackmann DE. Fibrous dysplasia of the temporal bone: the use of computerized tomography. Otolaryngol Head Neck Surg.1984; 92: 461-7.
[8]   | Reddy KT, Vinayak BC, Jefferis AF, Grieve DV. Fibrous dysplasia of the temporal bone. Ann Otol Rhinol Laryngol.1994; 103: 74-6.
[9]   | Sataloff RT, Graham MD, Roberts BR. Middle ear surgery in fibrous dysplasia of the temporal bone. Am J Otol.1985; 6: 153-6.
[10]   | Yagoda MR, Selesnick SH. Temporal bone fibrous dysplasia and cholesteatoma leading to the development of a parapharyngeal abscess. J Laryngol Otol.1994; 108: 51-3.
[11]   | MegerianCA, SoffermanRA, McKenna MJ, Eavey RD, NadolJrJB. Fibrous dysplasia of the temporal bone: ten new cases demonstrating the spectrum of otologicsequelae. Am J Otol.1995; 16: 408-19.
[12]   | DeKlotz TKH: Audio-otologic Phenotypes of Polyostotic Fibrous Dysplasia. Presented at the meeting of the American Academy of Otolaryngology San Francisco, CA. 2011.
[13]   | Sataloff RT, Graham MD, Roberts BR: Middle ear surgery in fibrous dysplasia of the temporal bone. Am J Otol. 1985; 6(2): 153-6.
[14]   | Megerian CA, Sofferman RA, McKenna MJ, Eavey RD, Nadol JB: Fibrous dysplasia of the temporal bone: ten new cases demonstrating the spectrum of otologic sequelae. Am J Otol. 1995; 16(4): 408-19.
[15]   | Nager GT, Kennedy DW, Kopstein E. Fibrous Dysplasia: A Review of the Disease and Its Manifestations in the Temporal Bone. Ann Otol Rhinol Laryngol 1982; 91(92): 1-52.
[16]   | Levine PA, Wiggins R, Archibald RW, Britt R. Ossifying Fibroma Of The Head And Neck: Involvement Of The Temporal Bone- An Unusual And Challenging Site. Laryngoscope 1981; 91: 720-5.
[17]   | Smouha EE, Edelstein DR, Parisier SC. Fibrous Dysplasia Involving the Temporal Bone: Report of Three New Cases. Am J Otol 1987(8): 103-7.
[18]   | Nager GT, Holliday MJ. Fibrous Dysplasia of the Temporal Bone. Ann Otol Rhinol Laryngol 1984; 93: 630-3.
[19]   | Lambert PR, Brackmann DE: Fibrous dysplasia of the temporal bone: the use of computerized tomography. Otolaryngol Head Neck Surg 1984; 92(4): 461-7.
[20]   | Lustig LR, Holliday MJ, McCarthy EF, Nager GT: Fibrous dysplasia involving the skull base and temporal bone. Archives of otolaryngology--head & neck surgery 2001; 127(10): 1239-47.
[21]   | Zaytoun GM, Dagher WI, Rameh CE: Recurrent facial nerve paralysis: an unusual presentation of fibrous dysplasia of the temporal bone. Eur Arch Otorhino laryngol 2008; 265(2): 255-9.
[22]   | Wang YC, Chen YA: Fibrous dysplasia of the temporal bone presenting as an external auditory canal mass. Oto laryngol Head Neck Surg 2009; 141(5): 655-6.
[23]   | Sataloff RT, Graham MD, Roberts BR: Middle ear surgery in fibrous dysplasia of the temporal bone. Am J Otol 1985; 6(2): 153-6.
[24]   | Pouwels AB, Cremers CW: Fibrous dysplasia of the temporal bone. J Laryngol Otol 1988; 102(2): 171-2.
[25]   | Kelly MH, Brillante B, Kushner H, GehronRobey P, Collins MT: Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone. Bone 2005; 37 (3): 388-94.
[26]   | Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. OsteoporosInt 2008; 19(1): 57-63.
[27]   | Matarazzo P, Lala R, Masi G, Andreo M, Altare F, de Sanctis C: Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome. J Pediatr Endocrinol Metab 2002; 15(3): 929-37.
[28]   | Chan B, Zacharin M: Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood. J Pediatr Endocrinol Metab 2006; 19 (1): 75-80.
[29]   | Chao K, Katznelson L: Use of high-dose oral bisphosphonate therapy for symptomatic fibrous dysplasia of the skull. Journal of neurosurgery 2008; 109(5): 889-92.
[30]   | Boyce AM, Chong WH, Yao J, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kassa-Vubu JZ, Molinolo AA, Bhattacharyya N, Collins MT: Denosumab treatment for fibrous dysplasia. J Bone Miner Res. 2012,
[31]   | Lee JS, FitzGibbon EJ, Chen YR, Kim HJ, Lustig LR, Akintoye SO et al. Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet Journal of Rare Diseases 2012(7): 1-19.